Stocksigma LogoStocksigma Logo

Sudarshan Pharma Updates on Proposed Stake Acquisition in Med Therapy Biotechnology

Sudarshan Pharma Industries announced that its proposal to acquire a 9.50% equity stake in USA-based Med Therapy Biotechnology Inc

Sudarshan Pharma Updates on Proposed Stake Acquisition in Med Therapy Biotechnology

Sudarshan Pharma Industries Ltd 路 Others (Uncategorized) 路 15 Sept 2026, 7:43 pm

Sudarshan Pharma Updates on Proposed Stake Acquisition in Med Therapy Biotechnology Sudarshan Pharma Industries announced that its proposal to acquire a 9.50% equity stake in USA-based Med Therapy Biotechnology Inc. remains under due diligence, pending board resolutions and final confirmation from Med Therapy's Board of Directors. Concurrently, proposals for company promoters Hemal Mehta (CMD) and Sachin Mehta (Joint MD) to acquire a 1.50% equity stake each are also undergoing due diligence and awaiting board approval. The company stated these were preliminary intimations and further updates will be disclosed once progress is finalized.

Original exchange filing (PDF)

More announcements from Sudarshan Pharma Industries Ltd

All Sudarshan Pharma Industries Ltd announcements